TrialBioMed research international2013

Effectiveness and safety of intensive triplet chemotherapy plus bevacizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer patients.

Gemma Bruera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.